27 November 2019

A hearing where people who applied for asylum during the period 2015-2017 could tell their experiences of coming to Sweden was held recently.
It was arranged in Stockholm by Linköping University in collaboration with a number of voluntary organizations.

Photo of texted stories from asylum seekers in Sweden.
Testimonies from asylum seekers in Sweden

Four years have passed since the government declared that Sweden needed a breather and introduced border controls and restrictions in the legislation to allow fewer people to seek asylum. But what really happened that autumn 2015 and the years to come? What was it like to come to Sweden as an asylum seeker?
The hearing, which was held on Saturday, November 23, aims to gather testimony from the asylum seekers.

Temporary residence permits a stress

The testimonies included waiting for decisions, the stress of living with temporary residence permits, moving from being a child to an adult in the asylum system and medical age assessments.

A testimony about the limited right to family reunification came from a woman with functional impairment who has been denied the right to be reunited with her children who remain in their home country.

Contact

Latest news from LiU

Woman looking up from working at her computer.

New research centre meets challenge of longer working lives

More and more people are working later into their lives – but what happens when health fails and this leads to sick leave? A new research centre at LiU is to find solutions for returning to work later in life and for a sustainable working life.

Inside Wadströms Exploranation Laboratory

LiU takes a big leap in global sustainability ranking

Linköping University climbs almost 200 places to reach position 156 in the QS World University Rankings: Sustainability2026. The ranking measures how higher education institutions around the world contribute to sustainability.

The shape of the cell nucleus influences cancer treatment

Cancer cells with a cell nucleus that is easily deformed are more sensitive to drugs that damage DNA, shows a new study. The results may also explain why combining certain cancer drugs can produce the opposite of the intended effect.